Allianz Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $204K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $512K | Sell |
|
|||||
|
2023
Q4 | $714K | Buy |
|
|||||
|
2023
Q3 | $425K | Hold |
|
|||||
|
2023
Q2 | $512K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $382K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $5.33M | Buy |
|
|||||
|
2018
Q3 | $5.02M | Buy |
|
|||||
|
2018
Q2 | $3.22M | Sell |
|
|||||
|
2018
Q1 | $4.58M | Sell |
|
|||||
|
2017
Q4 | $5.27M | Sell |
|
|||||
|
2017
Q3 | $7.53M | Sell |
|
|||||
|
2017
Q2 | $8.31M | Buy |
|
|||||
|
2017
Q1 | $6.8M | Sell |
|
|||||
|
2016
Q4 | $7.9M | Sell |
|
|||||
|
2016
Q3 | $13.3M | Buy |
|
|||||
|
2016
Q2 | $15.3M | Sell |
|
|||||
|
2016
Q1 | $27.8M | Buy |
|
|||||
|
2015
Q4 | $27.4M | Buy |
|
|||||
|
2015
Q3 | $18.8M | Sell |
|
|||||
|
2015
Q2 | $26.8M | Sell |
|
|||||
|
2015
Q1 | $27.7M | Sell |
|
|||||
|
2014
Q4 | $21.8M | Buy |
|
|||||
|
2014
Q3 | $18.6M | Buy |
|
|||||
|
2014
Q2 | $17.3M | Sell |
|
|||||
|
2014
Q1 | $18.7M | Buy |
|
|||||
|
2013
Q4 | $12.7M | Buy |
|
|||||
|
2013
Q3 | $7.7M | Buy |
|
|||||
|
2013
Q2 | $6.36M | Buy |
|